|4Feb 10, 4:55 PM ET

Chung Kevin 4

4 · SeaStar Medical Holding Corp · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

SeaStar Medical (ICU) CMO Kevin Chung Receives RSU Award

What Happened
Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp (ticker: ICU), was granted 15,000 restricted stock units (RSUs) on February 6, 2026. The award is recorded at $0.00 per share (Form 4 acquisition code "A"), meaning this is a compensation grant rather than an open‑market purchase or sale.

Key Details

  • Transaction date: 2026-02-06; Form 4 filed: 2026-02-10 (filed within the 2-business-day window).
  • Award: 15,000 RSUs; acquisition price shown as $0.00.
  • Vesting: RSUs vest in equal installments on the first, second and third anniversaries of February 6, 2026 (per footnote).
  • Shares owned after the transaction: not disclosed in the provided filing.
  • No 10b5-1 plan, tax‑withholding, or sale/disposition noted in this transaction.

Context
RSUs are a common form of executive compensation and vest over time, aligning executives’ interests with long‑term share performance. Because this is a grant (compensation) rather than a purchase or sale, it does not by itself signal a near‑term trading opinion by the insider — instead it reflects compensation/retention policy.

Insider Transaction Report

Form 4
Period: 2026-02-06
Chung Kevin
Chief Medical Officer
Transactions
  • Award

    Common Stock, par value $0.0001

    [F1]
    2026-02-06+15,00020,819 total
Footnotes (1)
  • [F1]Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026
Signature
/s/ Eric Schlorff as-attorney-in-fact|2026-02-10

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4 - KEVIN CHUNG 2-6-26 RSU GRANT